Bryant Ranch Prepack Inc. is recalling approximately 1,770 units of Valsartan 80 mg and 320 mg tablets because a cancer-causing impurity was found in the active ingredient used to make the medication. This recall involves 90, 60, and 28-count bottles of the 80 mg strength, and 90, 30, and 28-count bottles of the 320 mg strength. These prescription medications were distributed in Florida, Indiana, and Hawaii. Consumers should not stop taking their medication without first consulting a healthcare provider, as the risk of stopping the drug immediately may outweigh the risk of the impurity.
The active pharmaceutical ingredient (API) used to manufacture these tablets was found to contain a nitrosamine impurity, which is classified as a probable human carcinogen. Long-term exposure to this substance may increase the risk of developing cancer.
Healthcare consultation and pharmaceutical refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.